Composition for assisting in treating gout and increasing bone density and application of composition

A technology for increasing bone density and adjuvant therapy, applied in the field of adjuvant treatment of gout and compositions for increasing bone density, can solve the problems that western medicine cannot be taken for a long time, the effect is not significant enough, and the preparation is difficult, and achieves the elimination of harmful factors and no toxic and side effects. , the effect of dredging blood circulation

Inactive Publication Date: 2017-02-22
杨森健
View PDF5 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the drugs used clinically to treat osteoporosis are generally calcium, vitamin D, estrogen and the like, and the side effects of western medicine make it impossible to take them for

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition for assisting in treating gout and increasing bone density and application of composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] The present embodiment provides a composition for assisting the treatment of gout and increasing bone density. In parts by weight, the raw materials of the composition include 2000 parts of probiotic enzymes, 6 parts of fish bones, 6 parts of bovine bones, and 6 parts of bovine bone marrow. , 0.4 parts of amino acid chelated calcium, 17 parts of biological calcium carbonate, 2 parts of calcium gluconate, 0.3 parts of zinc gluconate, 2 parts of glucosamine hydrochloride, 2 parts of chondroitin sulfate, 6 parts of collagen, 0.4 parts of selenium, 6 parts of sour pomegranate, 4 parts of Chinese cabbage, 4 parts of wolfberry, 4 parts of poria cocos, 4 parts of jujube, 3 parts of ginger, 2 parts of Polygonatum and 2 parts of ginseng.

[0048] The combination is prepared into granules, which includes the following steps: mixing sour pomegranate, white cabbage, wolfberry, poria cocos, jujube, ginger, Polygonatum and ginseng, adding water and decocting, decocting 2-4 times, each...

Embodiment 2

[0050] The present embodiment provides a composition for assisting the treatment of gout and increasing bone density. In parts by weight, the raw materials of the composition include 2000 parts of probiotic enzymes, 5 parts of fish bones, 7 parts of bovine bones, and 5 parts of bovine bone marrow. , 0.5 parts of amino acid chelated calcium, 15 parts of biological calcium carbonate, 2 parts of calcium gluconate, 0.2 parts of zinc gluconate, 3 parts of glucosamine hydrochloride, 1 part of chondroitin sulfate, 7 parts of collagen, 0.2 parts of selenium, 7 parts of sour pomegranate, 3 parts of Chinese cabbage, 5 parts of wolfberry, 3 parts of poria cocos, 5 parts of jujube, 2 parts of ginger, 1 part of Polygonatum and 2 parts of ginseng.

[0051] The combination is prepared into granules, which includes the following steps: mixing sour pomegranate, white cabbage, wolfberry, poria cocos, jujube, ginger, Polygonatum and ginseng, adding water and decocting, decocting 2-4 times, each d...

Embodiment 3

[0053] The present embodiment provides a composition for assisting the treatment of gout and increasing bone density. In parts by weight, the raw materials of the composition include 2000 parts of probiotic enzymes, 7 parts of fish bones, 5 parts of bovine bones, and 7 parts of bovine bone marrow. , 0.2 parts of amino acid chelated calcium, 20 parts of biological calcium carbonate, 1 part of calcium gluconate, 0.5 parts of zinc gluconate, 1 part of glucosamine hydrochloride, 3 parts of chondroitin sulfate, 5 parts of collagen, 0.5 parts of selenium, 5 parts of sour pomegranate, 5 parts of Chinese cabbage, 3 parts of wolfberry, 5 parts of poria cocos, 3 parts of jujube, 3 parts of ginger, 2 parts of Polygonatum and 1 part of ginseng.

[0054] The combination is prepared into granules, which includes the following steps: mixing sour pomegranate, white cabbage, wolfberry, poria cocos, jujube, ginger, Polygonatum and ginseng, adding water and decocting, decocting 2-4 times, each de...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides composition for assisting in treating gout and increasing bone density. The composition comprises following raw materials in parts by weight: 1800-2200 parts of probiotics enzymes, 2-10 parts of fish bones, 2-10 parts of bovine bones, 2-10 parts of bovine bone marrow, 0.1-1 part of calcium amino acid chelate, 5-30 parts of biological calcium carbonate, 0.5-5 parts of calcium gluconate, 0.1-1 part of zinc gluconate, 0.5-5 parts of glucosamine hydrochloride, 0.5-5 parts of chondroitin sulfate, 2-10 parts of bone collagen, 0.1-1 part of selenium, 2-10 parts of sour pomegranate fruits, 2-10 parts of gynura divaricata, 2-10 parts of barbary wolfberry fruits, 2-10 parts of poria cocos, 2-10 parts of Chinese dates, 1-5 parts of fresh ginger, 1-5 parts of manyflower solomonseal rhizomes and 1-5 parts of ginseng. The composition is rich in functional component and calcium supplement, can effectively assist in treating gout and can increase the bone density and prevent osteoporosis. Besides, the invention also relates to an application of the composition.

Description

technical field [0001] The invention relates to the field of food or medicine, and particularly relates to a composition for auxiliary treatment of gout and increase of bone density and application thereof. Background technique [0002] Gout is a recurrent attack caused by increased purine biosynthesis and metabolism, excessive uric acid production or poor excretion of uric acid, resulting in elevated uric acid in the blood and deposition of urate crystals in the synovium, synovial bursa, cartilage and other tissues Inflammatory diseases. With the obvious changes in people's diet structure, the increase of high-energy and high-purine diet, coupled with the irregularity of people's life and lack of exercise, gout has become a health problem that plagues middle-aged and elderly people. In recent years, gout has increased Gradually showing a younger trend, the incidence rate is rapidly increasing, and the pain is severe and recurrent, which seriously plagues gout patients. At...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K38/39A61P19/06A61P19/10A23L33/16A61K36/9068A61K35/60A61K35/32A61K35/28A61K33/30A61K33/04A61K31/737A61K31/7008A61K31/315A61K31/191A61K35/745A61K35/747
CPCA61K35/745A23V2002/00A61K31/191A61K31/7008A61K31/737A61K33/04A61K33/30A61K35/28A61K35/32A61K35/60A61K35/747A61K36/076A61K36/185A61K36/258A61K36/28A61K36/725A61K36/815A61K36/8969A61K36/9068A61K38/39A61K2300/00A23V2200/30A23V2200/306A23V2250/1578A23V2250/1642A23V2250/5422
Inventor 杨森健
Owner 杨森健
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap